Johnson & Johnson to start late-stage coronavirus vaccine trial in September with up to 60,000 people

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.